FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

Grassley, Klobuchar Ask White House to Support Anti Pay-for-Delay Bill

Nov. 29, 2018
A A

Sens. Chuck Grassley (R-Iowa) and Amy Klobuchar (D-Minn.) appealed directly to the White House for help passing legislation that would ban pay-for-delay deals between drugmakers.

In a Nov. 8 letter, also sent to FDA Commissioner Scott Gottlieb, HHS Secretary Alex Azar and CMS Administrator Seema Varma, the lawmakers urge the administration to support the Preserve Access to Affordable Generics Act, which would impose limits on such settlements.

Pay-for-delay deals can delay the introduction of affordable generic drugs for years, according to Grassley and Klobuchar, and are estimated to cost consumers and taxpayers billions in higher drug costs.

“By promoting the timely introduction of affordable generic drugs, our legislation would increase prescription drug competition in U.S. markets, driving down prices and improving the quality of life for patients across the country,” the letter states.

View today's stories